Wenhuo Hu

10PUBLICATIONS
81CO-AUTHORS
Nanotoxicology, health and safetyNeurology and neuromuscular diseasesPredictive and prognostic markersCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 09, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants.

Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari

|Jan 03, 2024
Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis.

Wenyu Fu, Dmytro Vasylyev, Yufei Bi

|Nov 03, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita

|Nov 04, 2021
Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformation.

Yuxuan Liu, Zhimin Gu, Hui Cao

|Dec 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling.

Sizhi Paul Gao, Amber J Kiliti, Kai Zhang

|Jul 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer.

Aphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang

Pageof 2

Frequent Collaborators

3 joint publications

David B Solit

3 joint publications

Kwanghee Kim

3 joint publications

Timothy N Clinton

3 joint publications

Hikmat Al-Ahmadie